About: HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2000 (uk) im November 2000 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en novembre 2000 (fr) artículu científicu espublizáu en payares de 2000 (ast) scientific article published on 01 November 2000 (en)
publication date	wds:Q54888399-E4FA33B0-8CE0-432E-9BCF-5EF9FA3E5A37
publication date	2000-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q54888399-D5363325-57E2-46F2-B3A8-CCC2C47CFD03
language of work or name	English
cites work	wds:Q54888399-01B39033-7692-405A-ADB9-DF379FF89FC2 wds:Q54888399-0B2385FB-3B94-4AB7-9D93-76A67B4F5034 wds:Q54888399-0E37BE05-E13F-49EF-825C-E04423028BC0 wds:Q54888399-12AA3ED1-4A25-4545-911D-13B179B3535F wds:Q54888399-17EF2D7E-9260-4D6B-BB00-637CE235BD7D wds:Q54888399-207C39C5-D672-406A-B804-97FDD477E75F wds:Q54888399-208FB840-5B4E-4C87-84AB-C899E6F529D2 wds:Q54888399-3307E965-7F95-4642-B2D0-ABC8BE02B05F wds:Q54888399-3312E3B5-19DC-4C4A-8CD2-A9D76E96C9DF wds:Q54888399-383EA71F-2CD0-40E2-928B-9E1F8FCCCB8A wds:Q54888399-3D87AEC7-FA74-4A4E-B026-348F776A59D6 wds:Q54888399-3EF0E67D-294F-4B0A-9692-2CC2AC417A4C wds:Q54888399-4D4108CB-1977-46F8-8FF1-B92525731729 wds:Q54888399-4FF8CCE9-5323-495E-9BFD-4955A218704B wds:Q54888399-56A395F3-D04E-465E-8B67-5D7A24321A6C wds:Q54888399-59CBAF83-4955-4D24-9612-E6315B38A0A2 wds:Q54888399-78AC0CDC-0833-4314-84E5-4D391C13353F wds:Q54888399-7D7F911A-31A5-438C-99B0-07F9D6F2330B wds:Q54888399-831D06EB-4AFA-4FA3-A862-2E44AD0B292E wds:Q54888399-872BD251-F2DC-4BD2-8453-C4A5F8198880 wds:Q54888399-88AE6566-5C77-4081-9469-E6C0A5331963 wds:Q54888399-997C99CA-E61A-44EF-9E23-04D01B1B060A wds:Q54888399-B647E746-8DD5-428A-8A71-5AFE3D41C6BA wds:Q54888399-BC9C56C3-2B81-4E90-BE85-BD7BE6DB8FE7 wds:Q54888399-BD2A3F13-E23B-43FA-AF47-B62CDB7EF942 wds:Q54888399-CC5A6FA3-1A36-4C9D-9D86-DC41CB99308D wds:Q54888399-D2097A1F-E776-4087-8E6F-02ED71A626A0 wds:Q54888399-D395FB50-484A-41C8-9FD0-D617870CD0DB wds:Q54888399-D5B58C2C-D268-4A00-8424-0C288470CB98 wds:Q54888399-E3D0ACC3-29BC-4469-AEEF-9FCEC8139310 wds:Q54888399-F54FBA26-26C2-423B-B126-7E3897D5DA99 wds:Q54888399-F8CA93D4-565A-4CAE-B899-9DE597CD7456
cites work	G1 phase progression: cycling on cue Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. Regulation of transcription by proteins that control the cell cycle The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The retinoblastoma protein and cell cycle control Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells Lipid-Regulated Kinases: Some Common Themes at Last Translational control of p27Kip1 accumulation during the cell cycle Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor p70s6k function is essential for G1 progression Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase Statins do more than just lower cholesterol 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors Signal transduction via the MAP kinases: proceed at your own RSK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture Coronary artery bypass graft disease. Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts — Effects on Survival over a 15-Year Period The future of saphenous vein as a coronary artery bypass conduit Different Effects of Thrombin Receptor Activation on Endothelium and Smooth Muscle Cells of Human Coronary Bypass Vessels Different interactions of platelets with arterial and venous coronary bypass vessels Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes
author name string	wds:Q54888399-7177987D-7CB6-4737-AA5D-4F6B3ED25E97 wds:Q54888399-7DE39F1B-5CB3-4115-AC0D-3D1D2C7F67C0 wds:Q54888399-A20D5B4E-FFA9-495D-B0B7-8D347E7061ED wds:Q54888399-BBDDFA64-D79F-45DE-9574-6EED738E05D3 wds:Q54888399-E331C07D-B209-4745-8783-96DC7BD29850
author name string	Z Yang M I Turina B van der Loo T Malinski T Kozai
rdfs:label	HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (nl) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en-gb)
skos:prefLabel	HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (nl) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en-gb)
name	HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (nl) HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins (en-gb)
author	wds:Q54888399-2D8E44AB-410D-4421-9340-E238A6263EA2 wds:Q54888399-4D67C941-073A-4208-BD04-4D23A1EA8529 wds:Q54888399-C4D780C6-CA55-406E-9F6C-9D91D5624C81
author	Thomas Lüscher Mario Lachat Hema Viswambharan

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software